BACKGROUND: It is unclear from previous studies whether total or common subtypes of trans fatty acids are associated with fetal growth. OBJECTIVE: We examined associations of maternal trans fatty acid intake during pregnancy with fetal growth. DESIGN: We studied 1369 mother-child pairs participating in Project Viva-a prospective cohort study of pregnant women and their offspring. We assessed trans fatty acid consumption by using a validated semiquantitative food-frequency questionnaire in each of the first and second trimesters of pregnancy. We estimated fetal growth as the birth-weight-for-gestational-age (BW/GA) z value in infants born at term. RESULTS: We observed no associations of first-trimester trans fatty acid consumption with fetal growth. In the second trimester, the estimated mean (±SD) total trans fatty acid intake was 2.35 ± 1.07 g/d, of which 0.11 g was 16:1(n-7t), 1.78 g was 18:1(n-9t), 0.13 g was 18:2(n-6tt), 0.33 g was 18:2(n-6tc), and 0.12 g was 18:2(n-6ct). The mean (±SD) BW/GA was 0.24 ± 0.95 z score units. Total trans fatty acid consumption during the second trimester was positively associated with the fetal growth z score (0.29 units; 95% CI: 0.07, 0.51 units) for each 1% increment in energy from trans fatty acids as a replacement for carbohydrates. The associations were limited to the trans fatty acids 16:1t (0.12 units; 95% CI: 0.02, 0.22 units) and 18:2tc (0.53 units; 95% CI: 0.09, 0.96 units). CONCLUSION: A higher maternal intake of trans fatty acids, especially 16:1t and 18:2tc, during the second trimester of pregnancy was associated with greater fetal growth.
BACKGROUND: It is unclear from previous studies whether total or common subtypes of trans fatty acids are associated with fetal growth. OBJECTIVE: We examined associations of maternal trans fatty acid intake during pregnancy with fetal growth. DESIGN: We studied 1369 mother-child pairs participating in Project Viva-a prospective cohort study of pregnant women and their offspring. We assessed trans fatty acid consumption by using a validated semiquantitative food-frequency questionnaire in each of the first and second trimesters of pregnancy. We estimated fetal growth as the birth-weight-for-gestational-age (BW/GA) z value in infants born at term. RESULTS: We observed no associations of first-trimester trans fatty acid consumption with fetal growth. In the second trimester, the estimated mean (±SD) total trans fatty acid intake was 2.35 ± 1.07 g/d, of which 0.11 g was 16:1(n-7t), 1.78 g was 18:1(n-9t), 0.13 g was 18:2(n-6tt), 0.33 g was 18:2(n-6tc), and 0.12 g was 18:2(n-6ct). The mean (±SD) BW/GA was 0.24 ± 0.95 z score units. Total trans fatty acid consumption during the second trimester was positively associated with the fetal growth z score (0.29 units; 95% CI: 0.07, 0.51 units) for each 1% increment in energy from trans fatty acids as a replacement for carbohydrates. The associations were limited to the trans fatty acids 16:1t (0.12 units; 95% CI: 0.02, 0.22 units) and 18:2tc (0.53 units; 95% CI: 0.09, 0.96 units). CONCLUSION: A higher maternal intake of trans fatty acids, especially 16:1t and 18:2tc, during the second trimester of pregnancy was associated with greater fetal growth.
Authors: A C van Houwelingen; M M Foreman-van Drongelen; U Nicolini; K H Nicolaides; M D Al; A D Kester; G Hornstra Journal: Early Hum Dev Date: 1996-09-20 Impact factor: 2.079
Authors: Sheryl L Rifas-Shiman; Janet W Rich-Edwards; Walter C Willett; Ken P Kleinman; Emily Oken; Matthew W Gillman Journal: Paediatr Perinat Epidemiol Date: 2006-01 Impact factor: 3.980
Authors: Qi Sun; Jing Ma; Hannia Campos; Susan E Hankinson; JoAnn E Manson; Meir J Stampfer; Kathryn M Rexrode; Walter C Willett; Frank B Hu Journal: Circulation Date: 2007-03-26 Impact factor: 29.690
Authors: Wafaie W Fawzi; Sheryl L Rifas-Shiman; Janet W Rich-Edwards; Walter C Willett; Matthew W Gillman Journal: Ann Epidemiol Date: 2004-11 Impact factor: 3.797
Authors: Runyu Zou; Jeremy A Labrecque; Sonja A Swanson; Eric A P Steegers; Tonya White; Hanan El Marroun; Henning Tiemeier Journal: Eur J Epidemiol Date: 2022-09-15 Impact factor: 12.434